These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33212030)

  • 1. Determining dengue virus serostatus by indirect IgG ELISA compared with focus reduction neutralisation test in children in Cebu, Philippines: a prospective population-based study.
    Lopez AL; Adams C; Ylade M; Jadi R; Daag JV; Molloy CT; Agrupis KA; Kim DR; Silva MW; Yoon IK; White L; Deen J; de Silva AM
    Lancet Glob Health; 2021 Jan; 9(1):e44-e51. PubMed ID: 33212030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of single-dose, live, attenuated dengue vaccine in children with or without previous dengue on risk of subsequent, virologically confirmed dengue in Cebu, the Philippines: a longitudinal, prospective, population-based cohort study.
    Ylade M; Crisostomo MV; Daag JV; Agrupis KA; Cuachin AM; Sy AK; Kim DR; Ahn HS; Escoto AC; Katzelnick LC; Adams C; White L; de Silva AM; Deen J; Lopez AL
    Lancet Infect Dis; 2024 Jul; 24(7):737-745. PubMed ID: 38527474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of Dried Blood Spots Compared with Serum Samples for Measuring Dengue Seroprevalence in a Cohort of Children in Cebu, Philippines.
    Daag JV; Ylade M; Jadi R; Adams C; Cuachin AM; Alpay R; Aportadera ETC; Yoon IK; de Silva AM; Lopez AL; Deen J
    Am J Trop Med Hyg; 2021 Jan; 104(1):130-135. PubMed ID: 33146119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a new point-of-care test to determine prior dengue infection for potential use in pre-vaccination screening.
    Daag JV; Ylade M; Adams C; Jadi R; Crisostomo MV; Alpay R; Aportadera ETC; Yoon IK; White L; Deen J; de Silva AM; Lopez AL
    Clin Microbiol Infect; 2021 Jun; 27(6):904-908. PubMed ID: 32866651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody-based capture ELISA in the diagnosis of previous dengue infection.
    Sirivichayakul C; Limkittikul K; Chanthavanich P; Yoksan S; Ratchatatat A; Lim JK; Arunsodsai W; Sabchareon A
    Virol J; 2019 Oct; 16(1):125. PubMed ID: 31665014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an anti-dengue NS1 IgG ELISA to evaluate exposure to dengue virus.
    Nascimento EJM; George JK; Velasco M; Bonaparte MI; Zheng L; DiazGranados CA; Marques ETA; Huleatt JW
    J Virol Methods; 2018 Jul; 257():48-57. PubMed ID: 29567514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the performance of dengue virus IgG and IgG-capture enzyme-linked immunosorbent assays in seroprevalence study.
    Tsai JJ; Tsai CY; Lin PC; Chen CH; Tsai WY; Dai YC; Lin YC; Pedroso C; Brites C; Wang WK
    BMC Infect Dis; 2023 May; 23(1):301. PubMed ID: 37158835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of rapid diagnostic tests and conventional enzyme-linked immunosorbent assays to determine prior dengue infection.
    Bonaparte M; Zheng L; Garg S; Guy B; Lustig Y; Schwartz E; DiazGranados CA; Savarino S; Ataman-Önal Y
    J Travel Med; 2019 Dec; 26(8):. PubMed ID: 31616949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of Jamestown Canyon virus in the Japanese general population.
    Kato H; Satoh M; Kawahara M; Kitaura S; Yoshikawa T; Fukushi S; Dimitrova K; Wood H; Saijo M; Takayama-Ito M
    BMC Infect Dis; 2020 Oct; 20(1):790. PubMed ID: 33096994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dengue pre-vaccination screening test evaluation for the use of dengue vaccine in an endemic area.
    Limothai U; Tachaboon S; Dinhuzen J; Hunsawong T; Ong-Ajchaowlerd P; Thaisomboonsuk B; Fernandez S; Trongkamolchai S; Wanpaisitkul M; Chulapornsiri C; Tiawilai A; Tiawilai T; Tantawichien T; Thisyakorn U; Srisawat N
    PLoS One; 2021; 16(9):e0257182. PubMed ID: 34507347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of prior dengue-naïve Dengvaxia recipients with an increased risk for symptomatic dengue during fever surveillance in the Philippines.
    Dai YC; Sy AK; Jiz M; Tsai JJ; Bato J; Quinoñes MA; Reyes MAJ; Wang WK
    Front Immunol; 2023; 14():1202055. PubMed ID: 37554332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance Evaluation of a Dengue IgG Rapid Diagnostic Test Designed to Determine Dengue Serostatus as Part of Prevaccination Screening.
    Liberal V; Forrat R; Zhang C; Pan C; Bonaparte M; Yin W; Zheng L; Viscardi V; Wu Y; Ataman-Önal Y; Savarino S; Chen C
    Microbiol Spectr; 2022 Jun; 10(3):e0071121. PubMed ID: 35604130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of Dengue Virus Infection in Adults and Children in a Prospective Longitudinal Cohort in the Philippines.
    Alera MT; Srikiatkhachorn A; Velasco JM; Tac-An IA; Lago CB; Clapham HE; Fernandez S; Levy JW; Thaisomboonsuk B; Klungthong C; Macareo LR; Nisalak A; Hermann L; Villa D; Yoon IK
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004337. PubMed ID: 26845762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dengue serotype-specific seroprevalence among 5- to 10-year-old children in India: a community-based cross-sectional study.
    Garg S; Chakravarti A; Singh R; Masthi NR; Goyal RC; Jammy GR; Ganguly E; Sharma N; Singh MM; Ferreira G; Moureau A; Ojha S; Nealon J;
    Int J Infect Dis; 2017 Jan; 54():25-30. PubMed ID: 27825949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a dengue IgG indirect enzyme-linked immunosorbent assay and a Japanese encephalitis IgG indirect enzyme-linked immunosorbent assay for diagnosis of secondary dengue virus infection.
    Inoue S; Alonzo MT; Kurosawa Y; Mapua CA; Reyes JD; Dimaano EM; Alera MT; Saito M; Oishi K; Hasebe F; Matias RR; Natividad FF; Morita K
    Vector Borne Zoonotic Dis; 2010 Mar; 10(2):143-50. PubMed ID: 19874185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of the cutoff value for a commercial anti-dengue virus IgG immunoassay.
    Marrero-Santos KM; Beltrán M; Carrión-Lebrón J; Sanchez-Vegas C; Hamer DH; Barnett ED; Santiago LM; Hunsperger EA
    Clin Vaccine Immunol; 2013 Mar; 20(3):358-62. PubMed ID: 23302742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dengue virus seroprevalence study in Bangphae district, Ratchaburi, Thailand: A cohort study in 2012-2015.
    Limkittikul K; Chanthavanich P; Lee KS; Lee JS; Chatchen S; Lim SK; Arunsodsai W; Yoon IK; Lim JK
    PLoS Negl Trop Dis; 2022 Jan; 16(1):e0010021. PubMed ID: 34982768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods to discriminate primary from secondary dengue during acute symptomatic infection.
    Nguyen THT; Clapham HE; Phung KL; Nguyen TK; DInh TT; Nguyen THQ; Tran VN; Whitehead S; Simmons C; Wolbers M; Wills B
    BMC Infect Dis; 2018 Aug; 18(1):375. PubMed ID: 30086716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of dengue virus infection in US travelers who have lived in or traveled to dengue-endemic countries.
    Sanchez-Vegas C; Hamer DH; Chen LH; Wilson ME; Benoit C; Hunsperger E; Macleod WB; Jentes ES; Ooi WW; Karchmer AW; Kogelman L; Yanni E; Marano N; Barnett ED
    J Travel Med; 2013; 20(6):352-60. PubMed ID: 24165381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporation of IgG Depletion in a Neutralization Assay Facilitates Differential Diagnosis of Zika and Dengue in Secondary Flavivirus Infection Cases.
    Calvert AE; Boroughs KL; Laven J; Stovall JL; Luy BE; Kosoy OI; Huang CY
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29618505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.